Drugs approved since legislation to speed up the approval process at the US Food and Drug Administration are more likely to have received black box warnings or been withdrawn from the market, according to a new analysis appearing in Health Affairs.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.
The New York Stem Cell Foundation signs a lease for a new space.
Researchers gear up for an international meeting to discuss the ethics of gene editing.
In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.